MTS Help Center

European shares bounced on Friday on hopes that a vaccine for the novel coronavirus could be available in the United States before the end of the year, with a clutch of upbeat quarterly earnings also lifting sentiment after a torrid week.

Pfizer Inc PFE.N said it could file for U.S. authorisation of the COVID-19 vaccine it is developing with German partner BioNTech as early as November.

The news powered global stock markets and helped lift the pan-European STOXX 600 .STOXX by 1.3% in its best session in nearly three weeks.

Reference: CNBC